Agilon Health (NYSE:AGL) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $(0.75) by 238.67 percent. This is a 116.64 percent increase over losses of $(6.25) per share from the same period last year. The company reported quarterly sales of $1.495 billion which beat the analyst consensus estimate of $1.450 billion by 3.10 percent. This is a 7.15 percent increase over sales of $1.395 billion the same period last year.